Drug Discovery World
NOVEMBER 7, 2022
They subsequently applied additional bioinformatic approaches, using advanced computer technologies to identify genetic alterations in a patients’ DNA which may be causing disease but had been overlooked during routine testing. . It can also permit targeted screening of known disease complications and access to drug studies.
Drug Discovery World
MARCH 7, 2023
She founded Neuroute in 2019, with the aim of empowering patients from diverse backgrounds to participate in drug trials. Prior to Twist Bioscience, she worked at Agilent Technologies and at the University of Houston developing DNA and RNA parallel synthesis processes on solid support.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
JANUARY 17, 2024
ctDNA is fragmented DNA released from dead or dying cancer cells, through the process of apoptosis or necrosis. ctDNA is fragmented DNA released from dead or dying cancer cells, through the process of apoptosis or necrosis. Use of clinical RNA-sequencing in the detection of actionable fusions compared to DNA-sequencing alone.
Drug Discovery World
OCTOBER 6, 2022
Before drugs make it to market they have to pass through a gauntlet of stages involved in clinical trials. As such, patient selection for clinical trials has become an increasingly critical consideration for drug trial success.
The Pharma Data
MAY 17, 2021
Regeneron resumes enrollment in lymphoma drug trials ( Reuters ). Incyte’s vitiligo treatment meets main goal in late-stage trial ( Reuters ). No To Five, Yes To Three: NICE Decides On Funding For Drugs In England ( Pink Sheet ). Trump tax law cut what US drugmakers owed.
Expert insights. Personalized for you.
52 
Let's personalize your content